Revenue increased 179% and 190%, respectively, compared to the three and six-month periods in the prior year Call scheduled for today, August 7 , at 4:30 pm ET TUCSON, Ariz. , Aug. 07, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. …
TUCSON, Ariz., Aug. 03, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications and Oncologie, Inc. an innovative biotechnology company with operations in Boston and Shanghai, today announced the completion of a master agreement where the companies have agreed to partner on the development of biomarkers associated with Oncologie’s Immuno-oncology pipeline.
TUCSON, Ariz. , Aug. 03, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications and Oncologie, Inc. an innovative biotechnology company with operations in Boston and Shanghai , today …
TUCSON, Ariz. , Aug. 01, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced TJ Johnson, Chief Executive Officer of HTG will present at the Canaccord Genuity Growth …
TUCSON, Ariz. , July 24, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will report its financial results for the three and six months ended June 30, 2018 after …
The Worldwide Innovative Networking (WIN) Consortium at its annual symposium this week provided an update on its precision oncology clinical trial pipeline.
Join HTG for our symposium at ECP on Monday, September 18, 2018 to learn about Next-generation tumor molecular profiling, practical cases.
Interview with TJ Johnson, CEO of HTG Molecular, on the development of new oncology offerings with pharmaceutical companies and how QIAGEN and HTG have partnered to provide an entire workflow from biomarker discovery to companion diagnostic development.
Revenue increased 203% compared to the three-month period in the prior year Call scheduled for today, May 10 , at 4:30 pm ET TUCSON, Ariz. , May 10, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM) (HTG), a provider of instruments, reagents and services for …
The Panel will be available to researchers as part of an early access program TUCSON, Ariz. , May 10, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will …
TUCSON, Ariz. and HUNINGUE, France , May 07, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM) (“HTG”), a provider of instruments, reagents and services for molecular profiling applications, and Firalis S.A. (“Firalis”), a provider of bioanalytical services and biomarker-based …
Meet us in Berlin, Germany at the 102 Jahrestagung der Deutschten Gesellschaft für Pathologie Annual Meeting May 24 - 26 at Estrel Berlin
Page last updated March 20, 2023